---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-072425"
form_type: "8-K"
ticker: "FENC"
cik: "0001211583"
company_name: "FENNEC PHARMACEUTICALS INC."
filed_at: "2026-06-10T21:19:17+00:00"
generated_at: "2026-06-10T21:20:20.483091+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Fennec shareholders approve all proposals at 2026 annual meeting

## Summary
- All five director nominees elected: Islam, Rallis, Brughera, Cook, Hackman with ~20M+ votes each.
- Haskell & White LLP ratified as auditor: 26,091,716 for, 134,491 withheld, 29,165 against.
- Advisory vote on executive compensation approved: 19,326,750 for, 336,060 against.
- Advisory frequency set to every year: 18,235,648 for one year, minimal votes for other intervals.
- Amendments to 2020 Equity Incentive Plan and adoption of 2026 Equity Inducement Plan approved.

## SEC filing metadata
- accession: 0001104659-26-072425
- form_type: 8-K
- ticker: FENC
- cik: 0001211583
- company_name: FENNEC PHARMACEUTICALS INC.
- filed_at: 2026-06-10T21:19:17+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/tm2617550d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-072425
- JSON: https://secwatch.observer/filing/0001104659-26-072425.json
- Plain text: https://secwatch.observer/filing/0001104659-26-072425.txt

## Key facts
- Shareholder Votes
  FENNEC PHARMACEUTICALS INC. shareholders approved Advisory vote on the frequency of advisory votes on compensation at the 2026-06-10 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The resolution to vote on the advisory vote on the frequency of advisory votes on compensation of Corporations named executive officers was approved based on the following vote: Votes For Evey One Year 18,235,648 Votes For Evey Two Years 2,326 Votes For Evey Three Years 2,086219 Abstentions 49,294
  evidence_url: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm
- Shareholder Votes
  FENNEC PHARMACEUTICALS INC. shareholders approved Ratification and adoption of Fennec's 2026 Equity Inducement Plan at the 2026-06-10 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The resolution to ratify and approve the adoption of Fennec’s 2026 Equity Inducement Plan was approved based on the following vote:. Votes For 18,626,207 Votes Against 1,033,779 Abstentions 713,501 Broker Non-Votes 5,881,885
  evidence_url: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm
- Shareholder Votes
  FENNEC PHARMACEUTICALS INC. shareholders approved Election of five nominees to serve as directors at the 2026-06-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The following five (5) nominees were elected to serve as directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm
- Shareholder Votes
  FENNEC PHARMACEUTICALS INC. shareholders approved Appointment of Haskell & White LLP as independent public accounting firm and authorization to fix remuneration at the 2026-06-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration was approved based on the following vote: Votes For 26,091,716 Votes Withheld 134,491 Votes Against 29,165 Broker Non-Votes 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm
- Shareholder Votes
  FENNEC PHARMACEUTICALS INC. shareholders approved Advisory vote on executive compensation at the 2026-06-10 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The resolution to vote on the advisory vote on executive compensation was approved based on the following vote: Votes For 19,326,750 Votes Against 336,060 Abstentions 710,677 Broker Non-Votes 5,881,885
  evidence_url: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm
- Shareholder Votes
  FENNEC PHARMACEUTICALS INC. shareholders approved Approval of amendments to Corporation's 2020 Equity Incentive Plan at the 2026-06-10 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The resolution to approve certain amendments to Corporation’s 2020 Equity Incentive Plan was approved based on the following vote: Votes For (1) 17,425,439 Votes Against 1,429,951 Abstentions 751,944 Broker Non-Votes 5,881,885
  evidence_url: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.